HEART: Health Enhancement And Resilience Training

Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT01959126
Collaborator
(none)
70
1
1
30
2.3

Study Details

Study Description

Brief Summary

The purpose of this research study is to examine whether a stress reduction intervention can improve health, mood and biological markers of cellular stress and aging in a group of chronically-stressed maternal caregivers and healthy maternal controls.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Stress-reduction class
N/A

Detailed Description

This stress-reduction intervention was added into an ongoing observational study in May of 2013. The parent study is a prospective cohort study of the effects of chronic stress in a group of maternal caregivers with children on the autism spectrum and healthy controls whose children have no diagnosis. Study participants are being invited to enroll in a 12-week stress reduction course based on the principles of mindfulness. They will attend four six-hour workshops and participate in 12 weekly hour-long web video conferencing calls to reinforce what is taught in the workshops.

At the beginning and the end of the intervention, they complete self-report measures of psychological well-being and give saliva samples. Since the women are also participating in the longitudinal study, we have other before and after data for them. These include psycho-social measures, body measurements, psycho-physiology measurements, cognitive tests, actigraphy (for sleep), as well as saliva (for hormones), hair (for hormones) and blood (for telomeres, telomerase, gene expression, circulating hormones, inflammation and oxidative stress).

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Effect of a Stress Reduction Program Using Mindfulness Techniques on Markers of Cellular Stress and Aging
Actual Study Start Date :
May 1, 2013
Actual Primary Completion Date :
Nov 1, 2015
Actual Study Completion Date :
Nov 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stress-reduction class

Study participants enrolled in a 12-week stress reduction course based on the principles of mindfulness. They attended four six-hour workshops and participated in 12 weekly hour-long web video conferencing calls to reinforce what was taught in the workshops. We have two groups: chronically-stressed maternal caregivers of children on the autism spectrum and control mothers whose children have no significant psychiatric or physical impairment.

Behavioral: Stress-reduction class
Study participants enrolled in a 12-week stress reduction course based on the principles of mindfulness. They attended four six-hour workshops and participated in 12 weekly hour-long web video conferencing calls to reinforce what was taught in the workshops. We have two groups: chronically-stressed maternal caregivers of children on the autism spectrum and control mothers whose children have no significant psychiatric or physical impairment. Both groups received similar instruction.
Other Names:
  • mindfulness
  • Outcome Measures

    Primary Outcome Measures

    1. Salivary telomere length [Change from beginning to end of 12-week intervention]

      Participants will give saliva samples at the beginning and the end of the intervention. Salivary telomere length will be analyzed at both time points.

    Secondary Outcome Measures

    1. Psychological Well-Being [Change from beginning to end of 12-week intervention]

      We will collect perceived stress, acceptance and awareness of emotions and rumination at the beginning and at the end of the intervention.

    2. Telomere length from blood cells [Change over six months pre- and post-intervention]

      Since participants are also taking part in an ongoing non-interventional longitudinal study, they will provide blood samples at their 18-month study visit, which occurs before the start of the intervention, and at the 24-month study visit, which occurs after the end of the intervention. We will measure telomere length pre- and post-intervention in a variety of blood cell types.

    3. Telomerase [Change over 6 months pre- and post-intervention]

      Since participants are also taking part in an ongoing non-interventional longitudinal study, they will provide blood samples at their 18-month study visit, which occurs before the start of the intervention, and at the 24-month study visit, which occurs after the end of the intervention. We will measure telomerase pre- and post-intervention in a variety of blood cell types.

    4. Cognitive functioning [Change over six months pre- and post-intervention]

      Since participants are also taking part in an ongoing non-interventional longitudinal study, they will complete a battery of cognitive tasks at their 18-month study visit, which occurs before the start of the intervention, and at the 24-month study visit, which occurs after the end of the intervention. We will be able to assess performance pre- and post-intervention, to see if it improves after the stress-reduction training.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Must have at least one child between 2 and 16 at time of enrollment

    • Caregivers must have a child diagnosed in that age range diagnosed with an autism spectrum disorder.

    • Controls must have a healthy child in that age range. All women must be

    Exclusion Criteria:
    • Chronic disease, including recent history of cancer

    • History of psychiatric disorder, such as bipolar disorder or post-traumatic stress disorder

    • Medications, including statins, anti-anxiety drugs, and for controls only anti-depressants.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of California, San Francisco San Francisco California United States 94118

    Sponsors and Collaborators

    • University of California, San Francisco

    Investigators

    • Principal Investigator: Elissa S Epel, PhD, University of California, San Francisco
    • Principal Investigator: Elizabeth Blackburn, PhD, University of California, San Francisco
    • Principal Investigator: Jue Lin, PhD, University of California, San Francisco

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of California, San Francisco
    ClinicalTrials.gov Identifier:
    NCT01959126
    Other Study ID Numbers:
    • 10-02063
    First Posted:
    Oct 9, 2013
    Last Update Posted:
    Jan 26, 2021
    Last Verified:
    Jan 1, 2021
    Keywords provided by University of California, San Francisco

    Study Results

    No Results Posted as of Jan 26, 2021